This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

AbbVie files reply in support of dismissing US antitrust case over Humira

( June 27, 2025, 22:31 GMT | Official Statement) -- MLex Summary: AbbVie filed a reply in support of its motion to dismiss US claims accusing it of entering into illegal agreements with pharmacy benefit managers to ensure that Humira would be positioned favorably on formularies. It said that the type of “bundled” discounts alleged do not qualify as exclusionary conduct for an antitrust claim, and the plaintiff concedes it does not allege that AbbVie engaged in any other type of exclusionary conduct.See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections